Catalyst Funds Management Pty »

Bridgebio Pharma shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.0M 94k 74.48
2024-03-31 $118k 3.8k 30.92

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Bloom Energy Corp Ordinary Shares - Class A (BE)
Intel Corp. Ordinary Shares (INTC)
Microsoft Corporation Ordinary Shares (MSFT)
Credo Technology Group Holding Ordinary Shares (CRDO)
Lilly Ordinary Shares (LLY)
Vertiv Holdings Ordinary Shares - Class A (VRT)
Sterling Infrastructure Ordinary Shares (STRL)
Amazon.com Ordinary Shares (AMZN)
Qualcomm Ordinary Shares (QCOM)
Salesforce Ordinary Shares (CRM)
IonQ Ordinary Shares (IONQ)
Nextpower Ordinary Shares - Class A (NXT)
TTM Technologies Ordinary Shares (TTMI)
Fabrinet Ordinary Shares (FN)

View all positions for Catalyst Funds Management Pty

Top funds holding Bridgebio Pharma

Jupiter Topco
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
BlackRock
Viking Global Investors
Vanguard Capital Management
Vanguard Portfolio Management
Jane Street
UBS Group
Wellington Management Company
State Street Corporation
Two Sigma Investments
Aisling Capital Management
Citadel Advisors

View all funds holding Bridgebio Pharma